Programme - October 1^st - Monday

SYMPOSIUM LOCATION
Palazzo Cittanova – C.so Garibaldi 135 – Cremona (italy)

SESSION I
State of the art and perspectives
Chairmen: W.R. Miller, P. Pronzato

• h 08.30
  Interacting questions
  M. P. Brizzi, E. Milani
  
  
• h 09.00
  Overview on chemotherapy: concomitant or sequential?
  P. Valagussa
  
  
• h 09.20
  Overview on endocrine therapy
  F. Montemurro
  
  
• h 09.40
  Is concomitant endocrine and chemotherapy detrimental? The Cremona Breast Unit experience
  A. Berruti, A. Bottini
  
  
• h 10.00
  Evolving role of surgical treatment in primary chemotherapy
  R. Mansel
  
  
• h 10.20
  Questions and Discussion
  
  
• h 10.40
  Coffee Break

Chairmen: L. Dogliotti, L. Gianni, A.L. Harris

• h 11.00
  Selected oral communications
  
  
• h 11.30
  Special communication: The role of dose-dense chemotherapy in neo-adjuvant setting
  M. Danova
  
  
• h 12.00
  Keynote lecture: New approaches in neo-adjuvant: role of target therapies
  R. I. Nicholson
  
  
• h 12.30
  Lunch

SESSION II
Surrogate parameters: How can we rapidly assess the treatment efficacy?
Chairmen: P.F. Conte, M. Papotti

• h 14.00
  Pathological Complete Response (pCR): Different international classifications
  S.B. Fox
  
  
• h 14.20
  Biological predictive variables of pCR
  S. Bonardi
  
  
• h 14.40
  Are there any survival differences between pCR and DCIS?
  A. Makris
  
  
• h 15.00
  Is pCR a surrogate marker of treatment efficacy?
  Pro: G. von Minckwitz
  Contra: P. Bruzzi
  
  
• h 15.30
  Discussion
  
  
• h 15.45
  Coffee Break

Chairmen: M. Aglietta, F.Boccardo

• h 16.00
  MRI: detection tumour biology changes under treatment
  A. Padhani
  
  
• h 16.20
  PET and breast scintigraphy: applications in primary therapy?
  E. Bombardieri
  
  
• h 16.40
  Early response as a guide for further treatment
  M. Kaufmann
  
  
• h 17.00
  Discussion
  
  
• h 17.20
  Keynote lecture: Tumour microenvironment and its relation to the therapy
  M.I. Koukourakis
  
  
• h 17.50
  ARIA Symposium (Associazione per la Ricerca tra Italia e Australasia, Italian-Australian Research Association)
  The role of Italian Government in supporting bilateral projects
  N. Sassanelli
  ARIA in Queensland
  D. Kennedy
  
  
• h 18.00
  kConFab: The Australian consortium facilitating international breast cancer research
  H. Thorne
  
  
• h 18.20
  Biological background for immunotherapy in breast cancer
  D. Kennedy
  
  
• h 18.40
  Immunomodulating effect of aromatase inhibitor in breast cancer. A bilateral project
  S.B. Fox